Singular Genomics Systems Inc (OMIC)
0.4479
+0.01
(+2.26%)
USD |
NASDAQ |
May 09, 16:00
0.447
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Research and Development Expense (Quarterly): 11.69M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.69M |
| September 30, 2023 | 11.22M |
| June 30, 2023 | 12.62M |
| March 31, 2023 | 12.23M |
| December 31, 2022 | 10.76M |
| September 30, 2022 | 12.73M |
| June 30, 2022 | 12.06M |
| March 31, 2022 | 10.64M |
| Date | Value |
|---|---|
| December 31, 2021 | 9.455M |
| September 30, 2021 | 8.91M |
| June 30, 2021 | 7.682M |
| March 31, 2021 | 6.608M |
| December 31, 2020 | 5.816M |
| September 30, 2020 | 6.08M |
| June 30, 2020 | 5.325M |
| March 31, 2020 | 4.026M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.026M
Minimum
Mar 2020
12.73M
Maximum
Sep 2022
9.242M
Average
10.05M
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp | 81.70M |
| Azenta Inc | 8.493M |
| Harvard Bioscience Inc | 3.15M |
| Bionano Genomics Inc | 11.70M |
| Akoya Biosciences Inc | 4.67M |